For RETRO-RV respiratory virus detection, we validate nasopharyngeal and oropharyngeal swabs collected using standard specimen collection techniques. For RETRO-C cancer biomarker assays, we support whole blood, serum, and plasma samples. Detailed sample collection and handling instructions are provided in each product's Instructions for Use (IFU) document.

No. Current Retroindica diagnostic kits are designed and validated for professional use in clinical laboratories, point-of-care settings, and healthcare facilities. They require trained personnel for proper sample handling, test execution, and result interpretation to ensure accuracy and safety.

Our cloud quantitation platform uses smartphone cameras or dedicated readers to capture images of test strips. Advanced image processing algorithms automatically detect test and control lines, analyze intensity in multiple color spaces (RGB, HSV, LAB), and calculate test-to-control ratios. Results are uploaded to our secure cloud platform, which applies validated interpretation rules to generate semi-quantitative reports, PDF outputs, and aggregate analytics.

Yes. We provide comprehensive regulatory documentation packages for authorized partners, procurement teams, and regulatory bodies. This includes Instructions for Use (IFUs), analytical validation summaries, clinical study reports, technical datasheets, certificates of analysis (CoAs), batch records, and stability data. Documentation can be customized to meet specific tender or regulatory requirements.

Absolutely. Our contract development and manufacturing (CDMO) services cover end-to-end custom lateral flow assay development, from initial concept and feasibility studies through prototype development, analytical validation, clinical trials support, manufacturing scale-up, and regulatory documentation. We work with research institutions, biotechnology companies, and healthcare organizations to bring diagnostic concepts to market-ready reality.

Shelf life varies by product and storage conditions. Typically, our kits maintain stability for 18-24 months when stored according to specified temperature and humidity conditions. Real-time and accelerated stability studies are conducted for all products, with detailed stability data available in technical documentation.

RETRO-RV displays separate test lines for each target pathogen (SARS-CoV-2, Influenza A, Influenza B, RSV) along with a control line. Visual interpretation follows standard lateral flow principles: any visible test line indicates presence of the corresponding pathogen. For enhanced precision, our cloud quantitation system provides semi-quantitative T/C ratios and color index values that correlate with viral load, supporting more nuanced clinical decision-making.